MEDCAC Meeting Announcement

On December 7, 2022, the Centers for Medicare & Medicaid Services (CMS) will convene a panel of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC).

National Coverage Determinations (NCDs) resulting in Coverage with Evidence Development (CED) can expedite earlier Medicare beneficiary access to innovative technology while developing evidence and ensuring that systematic patient safeguards are in place to reduce the risks inherent to new technologies, or to new applications of older technologies. This MEDCAC meeting will examine the minimum CED criteria for clinical studies submitted for CMS approval.

The AHRQ Analysis of Requirements for Coverage with Evidence Development (CED) draft report, was released on September 7, 2022 and is open for public comment until September 28, 2022. The report and link to submit a public comment may be found at https://effectivehealthcare.ahrq.gov/products/coverage-evidence-development/draft-comment. The AHRQ report will be discussed during the December 7, 2022 MEDCAC.

Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page.

If you have any questions about this update, please emailcaginquiries@cms.hhs.gov.

You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS).

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com.

This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS).

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud 7500 Security Boulevard Baltimore MD 21244